JPH04502006A - ヌクレオシド類似体 - Google Patents
ヌクレオシド類似体Info
- Publication number
- JPH04502006A JPH04502006A JP2500243A JP50024389A JPH04502006A JP H04502006 A JPH04502006 A JP H04502006A JP 2500243 A JP2500243 A JP 2500243A JP 50024389 A JP50024389 A JP 50024389A JP H04502006 A JPH04502006 A JP H04502006A
- Authority
- JP
- Japan
- Prior art keywords
- ratio
- phosphorochloridate
- azidothymidine
- nucleoside
- phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (14)
- 1.式 ▲数式、化学式、表等があります▼ 〔式中、B=有機塩基 X=−Hまたは−N3 Z=−NR1R2、そして Y=−OR3または−NR4R5 ここで、R1,R2,R3,R4およびR5は、同一または異なり、−H、アル キル、アリール、アシル、置換アルキル、置換アリールおよび置換アシル基から 選ばれる〕 で示されるヌクレオシド類似体。
- 2.Y=−OR3である、請求項1に記載のヌクレオシド類似体。
- 3.R1=−H R2=−CHR6CO2R7(ここでR6およびR7は、同一または異なり、H 、アルキル、アリール、アシル、置換アルキル、置換アリールおよび置換アシル 基から選ばれる) である、請求項1または2に記載のヌクレオシド類似体。
- 4.R1=−H, R2=−CHR6CO2Me, Y=OR3, R6=−CHMe2,−CH2ph,−Me,−CH2CHMe2,−CHMe CH2Me、そして R3=Me,Et,Pr,Bu,Hex,2,2,2−トリクロロエチル である、請求項1〜3のいづれか一項に記載のヌクレオシド類似体。
- 5.当該化合物が、 3′−アジドチミジン−5′−(メチルメトキシバリニル)−ホスフェート; 3′−アジドチミジン−5′−(エチルメトキシバリニル)−ホスフェート; 3′−アジドチミジン−5′−(プロピルメトキシバリニル)−ホスフェート; 3′−アジドチミジン−5′−(ブチルメトキシバリニル)−ホスフェート; 3′−アジドチミジン−5′−(ヘキシルメトキシバリニル)−ホスフェート; 3′−アジドチミジン−5′−(エチルメトキシアラニニル)−ホスフェート; 3′−アジドチミジン−5′−(エチルメトキシフェニルアラニニル)−ホスフ ェート; 3′−アジドチミジン−5′−(エチルメトキシロイシェル)−ホスフェート; 3′−アジドチミジン−5′−(エチルメトキシイソロイシニル)−ホスフェー ト;または 3′−アジドチミジン−5′−(2,2,2−トリクロロエチルメトキシアラニ ニル)−ホスフェート;である、請求項4に記載のヌクレオシド類似体。
- 6.式 ▲数式、化学式、表等があります▼ 〔式中、R1=−H R2=−CH6CO2R7 R3,R6およびR7は同一または異なり、−H、アルキル、アリール、アシル 、置換アルキル、置換アリールおよび置換アシル基から選ばれる〕で示される化 学化合物。
- 7.当該化合物が、 メチルメトキシバリニル ホスホロクロリデート,エチルメトキシバリニル ホ スホロクロリデート,プロピルメトキシバリニル ホスホロクロリデート,ブチ ルメトキシバリニル ホスホロクロリデート,ヘキシルメトキシバリニル ホス ホロクロリデート,エチルメトキシアラニニル ホスホロクロリデート,エチル メトキシフェニルアラニニル ホスホロクロリデート, エチルメトキシロイシェル ホスホロクロリデート,エチルメトキシイソロイシ ニル ホスホロクロリデート, 2,2,2−トリクロロエチルメトキシアラニニルホスホロクロリデート、 である、請求項6に記載の化学化合物。
- 8.請求項1〜5のいずれか一項に記載のヌクレオシド類似体を、医薬的に許容 される賦形剤とともに含む医薬組成物。
- 9.非経口投与に適する形態である、請求項1〜5のいづれか一項に記載のヌク レオシド類似体。
- 10.医薬として使用するための、請求項1〜5のいづれか一項に記載のヌクレ オシド類似体。
- 11.請求項1〜5のいづれか一項に記載のヌクレオシド類似体を医薬的に許容 される賦形剤と一緒に合せることを含む、医薬組成物の調製方法。
- 12.当該処置を必要とするヒトまたは動物に、請求項1〜5のいづれか一項に 記載のヌクレオシド類似体の有効量を投与することを含む、処置方法。
- 13.ウィルス感染の処置用の医薬の製造における、請求項1〜5のいづれか一 項に記載のヌクレオシド類似体の使用。
- 14.請求項1〜5のいづれか一項に記載のヌクレオシド類似体の医薬として許 容される塩または付加化合物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8827337.0 | 1988-11-23 | ||
GB888827337A GB8827337D0 (en) | 1988-11-23 | 1988-11-23 | Nucleoside analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04502006A true JPH04502006A (ja) | 1992-04-09 |
Family
ID=10647305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2500243A Expired - Lifetime JPH04502006A (ja) | 1988-11-23 | 1989-11-23 | ヌクレオシド類似体 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0445201A1 (ja) |
JP (1) | JPH04502006A (ja) |
KR (1) | KR900701814A (ja) |
AU (1) | AU626360B2 (ja) |
DK (1) | DK95791A (ja) |
FI (1) | FI912489A0 (ja) |
GB (1) | GB8827337D0 (ja) |
WO (1) | WO1990005736A2 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2001401A1 (en) * | 1988-10-25 | 1990-04-25 | Claude Piantadosi | Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions |
CA2164717C (en) * | 1993-06-10 | 2009-10-20 | Louis S. Kucera | Method of combatting hepatitis b virus infection |
JP4259611B2 (ja) * | 1994-08-29 | 2009-04-30 | ウェイク フォレスト ユニバーシティ | ウィルス感染を治療するための脂質アナログ |
US7135584B2 (en) | 1995-08-07 | 2006-11-14 | Wake Forest University | Lipid analogs for treating viral infections |
US5981507A (en) * | 1995-12-14 | 1999-11-09 | Advanced Magnetics, Inc. | Polymeric carriers linked to nucleotide analogues via a phosphoramide bond |
WO1999049873A1 (en) * | 1998-03-27 | 1999-10-07 | Regents Of The University Of Minnesota | Nucleosides with antiviral and anticancer activity |
US7026469B2 (en) | 2000-10-19 | 2006-04-11 | Wake Forest University School Of Medicine | Compositions and methods of double-targeting virus infections and cancer cells |
US7309696B2 (en) | 2000-10-19 | 2007-12-18 | Wake Forest University | Compositions and methods for targeting cancer cells |
CN100469131C (zh) | 2001-08-31 | 2009-03-11 | 汤姆森许可公司 | 实现条件存取系统和传输、接收及处理内容的方法和设备 |
JP2008523082A (ja) | 2004-12-09 | 2008-07-03 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 抗菌活性および抗癌活性を有するヌクレオチド |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1414252A (en) * | 1921-12-29 | 1922-04-25 | William A Brubaker | Cushion tire |
JPS5185103A (ja) * | 1974-12-19 | 1976-07-26 | Bayer Ag | |
JPS57140206A (en) * | 1981-01-17 | 1982-08-30 | Bayer Ag | Car tire |
EP0081220A1 (de) * | 1981-12-07 | 1983-06-15 | Paul vom Stein & Co. | Laufrolle für Apparate, Möbel od. dgl. |
EP0159888A2 (en) * | 1984-04-16 | 1985-10-30 | The Uniroyal Goodrich Tire Company | Non-pneumatic tire |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3082203A (en) * | 1960-02-10 | 1963-03-19 | American Cyanamid Co | Novel nucleotide coenzymes |
US3280104A (en) * | 1964-04-13 | 1966-10-18 | Syntex Corp | 2', 3'-dideoxyribonucleoside and 2', 3'-dideoxyribonucleotide derivatives |
US3284440A (en) * | 1964-06-12 | 1966-11-08 | Merck & Co Inc | Phosphate esters of cytosine arabinoide and process for preparing same |
US3534017A (en) * | 1967-03-14 | 1970-10-13 | Kyowa Hakko Kogyo Kk | Process for the preparation of nucleoside-5'-diphosphates and triphosphates and mono- and oligo-nucleotidyl-nucleoside-5'-diphosphates and triphosphates |
DE3689976T2 (de) * | 1985-05-15 | 1995-03-16 | Wellcome Found | Therapeutische Nucleoside und deren Herstellung. |
GB2181128A (en) * | 1985-09-17 | 1987-04-15 | Wellcome Found | 3'-azidonucleosides |
-
1988
- 1988-11-23 GB GB888827337A patent/GB8827337D0/en active Pending
-
1989
- 1989-11-23 EP EP90900225A patent/EP0445201A1/en not_active Withdrawn
- 1989-11-23 WO PCT/GB1989/001401 patent/WO1990005736A2/en not_active Application Discontinuation
- 1989-11-23 JP JP2500243A patent/JPH04502006A/ja not_active Expired - Lifetime
- 1989-11-23 AU AU46542/89A patent/AU626360B2/en not_active Ceased
- 1989-11-23 KR KR1019900701554A patent/KR900701814A/ko not_active Application Discontinuation
-
1991
- 1991-05-22 FI FI912489A patent/FI912489A0/fi not_active Application Discontinuation
- 1991-05-22 DK DK095791A patent/DK95791A/da unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1414252A (en) * | 1921-12-29 | 1922-04-25 | William A Brubaker | Cushion tire |
JPS5185103A (ja) * | 1974-12-19 | 1976-07-26 | Bayer Ag | |
JPS57140206A (en) * | 1981-01-17 | 1982-08-30 | Bayer Ag | Car tire |
EP0081220A1 (de) * | 1981-12-07 | 1983-06-15 | Paul vom Stein & Co. | Laufrolle für Apparate, Möbel od. dgl. |
EP0159888A2 (en) * | 1984-04-16 | 1985-10-30 | The Uniroyal Goodrich Tire Company | Non-pneumatic tire |
Also Published As
Publication number | Publication date |
---|---|
KR900701814A (ko) | 1990-12-04 |
EP0445201A1 (en) | 1991-09-11 |
DK95791D0 (da) | 1991-05-22 |
GB8827337D0 (en) | 1988-12-29 |
WO1990005736A2 (en) | 1990-05-31 |
DK95791A (da) | 1991-05-22 |
AU626360B2 (en) | 1992-07-30 |
WO1990005736A3 (en) | 1990-07-12 |
FI912489A0 (fi) | 1991-05-22 |
AU4654289A (en) | 1990-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3628324B2 (ja) | ホスホトリエステルタイプ生物学的活性化合物 | |
US5512671A (en) | Ether lipid-nucleoside covalent conjugates | |
AU2012223012B2 (en) | Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer | |
McGuigan et al. | Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT | |
CA1336820C (en) | Fluorinated nucleosides and process for treating retrovirus infections therewith | |
FI104176B (fi) | Menetelmä nukleosidien uusien antiviraalisten forfolipidijohdannaisten valmistamiseksi | |
EP0533825B1 (en) | Ether lipid-nucleoside covalent conjugates | |
PT821690E (pt) | Análogos de nucleotídeos para tratamento de infeções virais | |
JPH0780898B2 (ja) | 抗ウイルスヌクレオシド | |
MX2013013570A (es) | Profarmacos de monofosfato de purina para el tratamiento de infecciones virales. | |
KR20110115601A (ko) | 암 및 바이러스 감염 치료용 퓨린 뉴클레오시드 모노포스페이트 프로드럭 | |
CN103403014A (zh) | O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途 | |
JPH04502006A (ja) | ヌクレオシド類似体 | |
US6686462B2 (en) | Antiviral compounds and methods of administration | |
AU714236B2 (en) | New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents | |
JPH06510529A (ja) | 目標とする触媒性たんぱく質により活性化されるプロドラッグ | |
CN103339136A (zh) | 尿苷二-或三-磷酸衍生物以及其用途 | |
US5770725A (en) | Phosphotriester type biologically active compounds | |
JP2976436B2 (ja) | 新規オリゴリボヌクレオチド誘導体及び抗ウイルス剤への使用 | |
Rosowsky et al. | Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3′-azido-3′-deoxythymidine | |
RU2243972C1 (ru) | Фосфорамидаты нуклеозидных аналогов - ингибиторы репродукции вируса иммунодефицита человека | |
US6914052B2 (en) | Selective anti-viral nucleoside chain terminators | |
JPH10507763A (ja) | L−ピラノシルヌクレオシド | |
US6020482A (en) | Phosphotriester type biologically active compounds | |
KR101323698B1 (ko) | Azt의 변형된 5'-포스포네이트 - 잠재적 항바이러스제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080227 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090227 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090227 Year of fee payment: 11 |